These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1482710)

  • 41. IL-12 gene therapy using direct injection of tumors with genetically engineered autologous fibroblasts.
    Tahara H; Lotze MT; Robbins PD; Storkus WJ; Zitvogel L
    Hum Gene Ther; 1995 Dec; 6(12):1607-24. PubMed ID: 8664385
    [No Abstract]   [Full Text] [Related]  

  • 42. Gene transfer in vivo with DNA-liposome complexes: lack of autoimmunity and gonadal localization.
    Nabel EG; Gordon D; Yang ZY; Xu L; San H; Plautz GE; Wu BY; Gao X; Huang L; Nabel GJ
    Hum Gene Ther; 1992 Dec; 3(6):649-56. PubMed ID: 1482705
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic control of sensitivity to Moloney leukemia virus in mice. IV. Phenotypic heterogeneity of the leukemic mice.
    Boyer B; Gisselbrecht S; Debre P; McKenzie I; Levy JP
    J Immunol; 1980 Oct; 125(4):1415-20. PubMed ID: 7410844
    [No Abstract]   [Full Text] [Related]  

  • 44. The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivo.
    Niimi M; Pearson TC; Larsen CP; Alexander DZ; Hollenbaugh D; Aruffo A; Linsley PS; Thomas E; Campbell K; Fanslow WC; Geha RS; Morris PJ; Wood KJ
    J Immunol; 1998 Nov; 161(10):5331-7. PubMed ID: 9820506
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Suppression of the antibody response to a polymorphic peptide from the platelet alloantigen integrin beta3 with low molecular weight antigen arrays.
    Watson DC; Reim J; Dintzis HM
    J Immunol; 1996 Apr; 156(7):2443-50. PubMed ID: 8786303
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biologic modification of the immune response in mouse cardiac isografts using gene transfer.
    Fyfe AI; Ardehali A; Laks H; Drinkwater DC; Lusis AJ
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S165-70. PubMed ID: 8719479
    [No Abstract]   [Full Text] [Related]  

  • 47. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines.
    Fenton RG; Turcovski-Corrales SM; Taub DD
    J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.
    Chang KM; Gruener NH; Southwood S; Sidney J; Pape GR; Chisari FV; Sette A
    J Immunol; 1999 Jan; 162(2):1156-64. PubMed ID: 9916747
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Progress and limitations in cancer gene therapy.
    Heo DS
    Genet Med; 2002; 4(6 Suppl):52S-55S. PubMed ID: 12544489
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vascular attack by 5,6-dimethylxanthenone-4-acetic acid combined with B7.1 (CD80)-mediated immunotherapy overcomes immune resistance and leads to the eradication of large tumors and multiple tumor foci.
    Kanwar JR; Kanwar RK; Pandey S; Ching LM; Krissansen GW
    Cancer Res; 2001 Mar; 61(5):1948-56. PubMed ID: 11280751
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Kinetic studies of alloantibody response to donor alloantigens following donor-specific transfusion and lung transplantation in rats.
    Hara M; Shibata K; Kimura H; Shinomiya T; Koga Y
    Transplant Proc; 1995 Apr; 27(2):1577-9. PubMed ID: 7725415
    [No Abstract]   [Full Text] [Related]  

  • 52. Studies on the induction of tolerance to alloantigens. I. The abrogation of potentials for delayed-type-hypersensitivity response to alloantigens by portal venous inoculation with allogeneic cells.
    Qian J; Hashimoto T; Fujiwara H; Hamaoka T
    J Immunol; 1985 Jun; 134(6):3656-61. PubMed ID: 2580893
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phenotype, immunological reactivity and cytokine production profile of Peyer's patch cells from mice immunized orally with allogeneic cells.
    Fric J; Krulová M; Zajícová A; Holán V
    Folia Biol (Praha); 2000; 46(3):119-25. PubMed ID: 10925783
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tolerance induction by anti-CD2 plus anti-CD3 monoclonal antibodies: evidence for an IL-4 requirement.
    Punch JD; Tono T; Qin L; Bishop DK; Bromberg JS
    J Immunol; 1998 Aug; 161(3):1156-62. PubMed ID: 9686574
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Administration, maintenance and expression of foreign genetic body in eukaryotic systems: approaches to gene therapy].
    Ivanov VI; Liashko VN
    Vestn Ross Akad Med Nauk; 1993; (9):32-5. PubMed ID: 7510181
    [No Abstract]   [Full Text] [Related]  

  • 56. Human gene transfer protocols: summary table.
    Hum Gene Ther; 2000 Dec; 11(18):2619. PubMed ID: 11119426
    [No Abstract]   [Full Text] [Related]  

  • 57. Gene transfer therapy in cancer.
    Dorudi S; Northover JM; Vile RG
    Br J Surg; 1993 May; 80(5):566-72. PubMed ID: 8155107
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Immunotherapy and gene therapy of neoplasms].
    Górski A
    Pol Arch Med Wewn; 1993 Sep; 90(3):177-9. PubMed ID: 8284240
    [No Abstract]   [Full Text] [Related]  

  • 59. Human gene marker/therapy clinical protocols.
    Hum Gene Ther; 1998 Dec; 9(18):2805-52. PubMed ID: 9874278
    [No Abstract]   [Full Text] [Related]  

  • 60. Big changes coming to biosafety oversight of clinical gene transfer.
    Emery DW
    Mol Ther; 2014 Aug; 22(8):1402. PubMed ID: 25082087
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.